John Rogers

Last Update: 02-14-2017

Number of Stocks: 191
Number of New Stocks: 14

Total Value: $8,471 Mil
Q/Q Turnover: 5%

Countries: USA
Details: Top Buys | Top Sales | Top Holdings  Embed:

John Rogers Watch

  • 8 Stocks With Strong Yields but Falling Prices

    According to the GuruFocus All-in-One Screener, the following stocks have high dividend yields but performed poorly over the past 12 months.

    Blackrock Virginia Municipal Bond Trust’s (BHV) dividend yield is 4.82% with a payout ratio of 0.55%. Over the past 52 weeks the price declined 14.2%, and the stock is now trading with a price-earnings (P/E) ratio of 10.9 and a price-sales (P/S) ratio of 14.9.


  • John Rogers' Ariel Fund January Commentary

    In January, our monthly commentary typically focuses on the prior year’s asset flows, since they often a reveal a lot about investor sentiment. As we have noted before, asset flows have followed a different pattern in the wake of the great financial crisis. Specifically, bonds tended to receive inflows, domestic equity saw outflows, and passive management began dominating active management—mainly but not only in equities. More subtly, a long-standing preference for funds with strong short-term performance became even more pronounced.


  • 8 High-Yield Stocks With a Negative 1-Year Performance

    According to the GuruFocus All-in-One Screener, the following stocks have high dividend yields but performed poorly over the past 12 months.

    United-Guardian Inc.’s (NASDAQ:UG) dividend yield is 4.96% with a payout ratio of 1.73%. Over the past 52 weeks however, the price declined 23.1%, and the stock is now trading with a price-earnings (P/E) ratio of 30.90 and a price-sales (P/S) ratio of 7.2.


  • John Rogers Comments on JLL

    Also, real estate company JLL (NYSE:JLL) declined –10.89% on disappointing earnings. In early November the company reported quarterly earnings of $1.42, significantly below consensus of $2.00. Revenues were strong, but the impact of an acquisition, higher technology spending, a decline in incentive fees, and a significant write-down of receivables all hurt the bottom line. We think the quarter featured a rare confluence of one-time factors. To our minds, the long-term value of one of the top two global real estate players remains stable.

    From John Rogers (Trades, Portfolio)' Ariel Fund fourth quarter 2016 commentary.


  • John Rogers Comments on Charles River Laboratories Intl

    Other holdings underperformed. Scientific research firm Charles River Laboratories Intl, Inc. (NYSE:CRL) slid –8.58% due to contracting customer spending and a general downturn in health care stocks. Like other similar firms, Charles River expanded over the last 15 years to be able to handle peak medical research, but as drug companies scaled back, there was clearly overcapacity. The company’s drug discovery business is still a bit slack. That said, many health care stocks slid this quarter during a huge rotation to financials. We think the current issues are largely cyclical but the secular push toward solving medical problems through pharmaceuticals remains intact—a long-term tailwind for Charles River.

    From John Rogers (Trades, Portfolio)' Ariel Fund fourth quarter 2016 commentary.


  • John Rogers Comments on Keysight Technologies

    In the last quarter of the year, we added one new position in Ariel Appreciation Fund We purchased Keysight Technologies, Inc. (NYSE:KEYS), a leading test and measurement business for electronics. The company’s long history dates back to its formation as the measurement business of Hewlett-Packard (NYSE:HPE), which has resulted in deeply rooted relationships, leading market share, and a seat at the table during the development of new technologies. Recently spun-off from Agilent Technologies, Inc. (NYSE:A), investors are discarding the shares due to a perceived lack of near-term growth prospects. We see this as an attractive long-term opportunity to own a niche market leader with excellent free cash flow generation. We think it is well-positioned to benefit from several longer-term tailwinds, including 5G wireless testing and growing demand for modular solutions, software-based testing and recurring services.

    From John Rogers (Trades, Portfolio)' Ariel Appreciation Fund fourth quarter 2016 commentary.  

  • John Rogers Comments on Thermo Fisher Scientific Inc.

    Also, scientific research supplier Thermo Fisher Scientific Inc. (NYSE:TMO) dropped –11.20% despite an earnings beat. The company reported earnings per share of $2.03 in late October, well ahead of the $1.97 consensus estimate; it also closed its acquisition of electron microscope maker FEI Company. Health care stocks were generally weak in November and December as investors rotated away from defensive stocks toward more aggressive ones. In our view, the company remains on the right track.

    From John Rogers (Trades, Portfolio)' Ariel Appreciation Fund fourth quarter 2016 commentary.  

  • John Rogers Comments on Zimmer Biomet Holdings

    Other holdings underperformed. Orthopedic specialist Zimmer Biomet Holdings, Inc. (NYSE:ZBH) fell –20.44% after cutting guidance and admitting internal supply issues. Earnings were in-line, but revenue was negatively impacted by inventory for some high-end products. The company subsequently cut full-year earnings guidance from $8.00 per share to $ 7.95 per share. We view the supply problem as a short-term issue and believe the long-term future is bright for this best-in-class brand.

    From John Rogers (Trades, Portfolio)' Ariel Appreciation Fund fourth quarter 2016 commentary.  

  • John Rogers Comments on Northern Trust Corp

    In addition, wealth management firm Northern Trust Corp. (NASDAQ:NTRS) surged +31.58% on broad news that boosted many financial companies. Donald Trump’s unexpected win is good news for banks, asset managers, and investment banks. And, as anticipated, in mid-December the Federal Reserve raised its federal funds target rate 25 basis points to the 0.50% to 0.75% range, which helps boost bank profits on deposits. The Northern Trust is performing well, but its recent rise was due to external events.

    From John Rogers (Trades, Portfolio)' Ariel Appreciation Fund fourth quarter 2016 commentary.  

  • John Rogers Comments on Bristow Group Inc.

    Some holdings in the portfolio advanced considerably. Helicopter transportation company Bristow Group Inc. (NYSE:BRS) ascended +46.83% after recently secured financing put Wall Street at ease. The Street had worried the company would become financially distressed like a top competitor given the oil industry’s woes. Instead, Bristow arranged $300 million in debt, secured by a portion of its own helicopter fleet. In addition, oil rose during the year and the quarter, giving the stock a mild boost as well. We think its shares are undervalued given the company’s significant assets and depressed earnings.

    From John Rogers (Trades, Portfolio)' Ariel Appreciation Fund fourth quarter 2016 commentary.  

  • John Rogers' Ariel Fund 4th Quarter Commentary

    Entering the fourth quarter of 2016, it appeared domestic stocks would have a solid year and international equities a lackluster, yet positive one. After a divergent quarter, we had a great year in the U.S. and a flat year abroad. For 2016, the large-cap S&P 500 Index gained +11.96%, the small-cap Russell 2000 Index leapt +21.31%, while the developed-market MSCI EAFE Index eked out a +1.00% gain. As many know, the big surge after the surprising U.S. Presidential Election became known as the “Trump Bump.” The disparity between large-caps’ single digit fourth quarter gains and small-caps’ big run stems from the President-Elect’s plan to slash corporate taxes. Perhaps more importantly, however, the gains suggest optimism the economic expansion will continue. Globally, pessimism has held sway for some time. Since a July 3, 2014 peak, the MSCI EAFE Index is down -9.23% cumulatively through December 31, 2016. This index is clearly in a bear market: down for two and a half years and at one point off -22.15% cumulatively. This quarter, Ariel Fund gained +7.75%, behind the Russell 2500 Value Index’s +9.34% gain but ahead of the +6.12% rise of the Russell 2500 Index.


  • John Rogers' Ariel Appreciation Fund 4th Quarter Commentary

    Quarter Ended December 31, 2016


  • John Rogers Muses on Risk in Ariel Funds December Commentary

    Happy New Year to you and Happy Birthday to our global portfolios! Two years ago we celebrated their three-year records and first set of Morningstar Ratings, so it makes sense to do so again as they turn five. We think we have reason to be proud of Ariel International Fund and Ariel Global Fund’s performance and hope you agree.


  • Gilead Sciences Must Answer to Investors After a Disappointing 2016

    Gilead Sciences Inc. (NASDAQ:GILD) delivered a poor performance last year. The stock lost over 24% in 2016, caused by a drop in sales of products that treat hepatitis C. According to Ben Levinsohn in a Barron's article, the decline was also attributed to the company’s lack of a plan for the future.


  • Gurus Expand Positions in Entertainment and Travel Companies

    Among the industries, the entertainment and travel industries have high institutional and insider ownership. Such companies include Cinemark Holdings Inc. (NYSE:CNK), Century Casinos Inc. (NASDAQ:CNTY) and Royal Caribbean Cruises Ltd. (NYSE:RCL). As gurus expand their positions in these companies, such companies have good value potential in early 2017.

    High institutional and insider ownership suggest strong value potential


  • John Rogers Boosts Berkshire, Rockwell Collins, Tiffany

    John Rogers (Trades, Portfolio) founded Ariel Investment LLC in 1983, and the firm now has a total value of $8.267 billion. During the third quarter the guru’s largest buys were the following:

    The investor raised his position in Berkshire Hathaway Inc. Class B (BRK.B) by 151.06% with an impact of 0.44% on the portfolio.


  • Ariel Investments Vice Chair Discusses Finding Attractive Stocks

    Ariel Investments Vice Chairman Bob Bobrinskoy spoke to CNBC Friday about how to find attractive stocks in the higher market. Bobrinskoy said investors should compare stocks to their intrinsic value rather than the market, which has gone up since October.

    Low-priced stocks were merely slightly harder to find, he said. His picks were: KKR & Co. (NYSE:KKR), Borgwarner (NYSE:BWA) and Zimmer Holdings (NYSE:ZBH). The investor also discussed the Dow, small caps and EU banks.


  • John Rogers' Ariel Fund November Commentary

    As you know, we have been commemorating the 30th anniversary of our flagship Ariel Fund throughout 2016. And while we have been able to describe how many U.S. equity funds have 30 years of history (207), and how many in that group have had the same manager (just 19), we had to wait for a very important number: the 30-year return figure. At long last, a week into November 2016 we received the 30-year since inception number, which we discuss below.


  • Chuck Royce’s Top 3 New Holdings

    Chuck Royce (Trades, Portfolio) of Royce & Associates bought 51 new holdings in the third quarter. His top three new holdings are American Woodmark Corp. (NASDAQ:AMWD), Houlihan Lokey Inc. (NYSE:HLI) and Skechers (NYSE:SKX).

    Royce is the chairman and portfolio manager at Royce & Associates. His firm utilizes an active, bottom-up, risk-conscious and fundamental investment approach. It invests primarily in smaller companies and seeks great stocks that are trading for less than they estimate the company is worth.


  • Snap-on: Ratcheting Up Margins and Other Vital Metrics

    Shares of Snap-on Inc. (NYSE:SNA) have jumped 13% since third-quarter earnings were announced a month ago.

    Snap-on is behind all those white vans that sell wrenches and sockets at auto repair shops and dealerships. At least, that is the traditional business; it now operates three other segments that make money as well.


Add Notes, Comments

If you want to ask a question or report a bug, please create a support ticket.

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)